IDEAYA Biosciences (IDYA) Operating Leases (2019 - 2026)
IDEAYA Biosciences (IDYA) reported Operating Leases of $28.12 million for Q2 2026, up 7.0% from $26.28 million a year earlier but down 0.5% from the prior quarter.
Powered by 
Analysis
IDEAYA Biosciences (IDYA) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, IDEAYA Biosciences posted Operating Leases of $27.58 million, up 46.1% from FY2024.
- Operating Leases has a five-year compound annual growth rate of 39.7% (FY2020 to FY2025).
- By year, Operating Leases came in at $18.87 million in FY2024, $1.13 million in FY2023 (-30.2%), $1.61 million in FY2022 (-53.7%) and $3.48 million in FY2021 (-32.8%).
- Five-year quarterly Operating Leases spans a low of $611,000 in Q2 2023 and a high of $28.25 million in Q1 2026.
- Year over year, Operating Leases has now increased in each of the last four quarters, with growth averaging 26.6% over the last four quarters.
- The high point for year-over-year Operating Leases in five years was Q2 2024 (growth of 106.7%); the low point was Q2 2023 (a decline of 76.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $28.25 million (Q1 2026), $27.58 million (Q4 2025) and $26.92 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | IDEAYA Biosciences | 3.68 Bn | 757.04 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 28.12 Mn |
| Mar 31, 2026 | 28.25 Mn |
| Dec 31, 2025 | 27.58 Mn |
| Sep 30, 2025 | 26.92 Mn |
| Jun 30, 2025 | 26.28 Mn |
| Mar 31, 2025 | 25.66 Mn |
| Dec 31, 2024 | 18.87 Mn |
| Sep 30, 2024 | 18.80 Mn |
| Jun 30, 2024 | 1.26 Mn |
| Mar 31, 2024 | 1.26 Mn |
| Dec 31, 2023 | 1.13 Mn |
| Jun 30, 2023 | 611,000.00 |
| Mar 31, 2023 | 1.12 Mn |
| Dec 31, 2022 | 1.61 Mn |
| Sep 30, 2022 | 2.10 Mn |
| Jun 30, 2022 | 2.57 Mn |
| Mar 31, 2022 | 3.03 Mn |
| Dec 31, 2021 | 3.48 Mn |
| Sep 30, 2021 | 3.92 Mn |
| Jun 30, 2021 | 4.36 Mn |
API Access
IDEAYA Biosciences Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=IDYA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "IDYA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=IDYA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();